Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Deleveraging Programme Update

20 Jun 2024 07:00

RNS Number : 1271T
Phoenix Group Holdings PLC
20 June 2024
 

 

Phoenix Group Holdings plc

LEI: 2138001P49OLAEU33T68

 

Phoenix Group deleveraging programme update

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") is pleased to announce the completion of the initial phase of its deleveraging programme, comprising a debt redemption and refinancing exercise.

This is in support of the Group's stated deleveraging programme, where it intends to repay at least £500 million of debt and is targeting a Solvency II leverage ratio of c.30% by the end of 2026.

On 3 May 2024 the Group announced that it would fully redeem its £250 million Tier 2 notes due 2029 on their first call date of 13 June 2024, which have now been fully repaid.

The Group has also prudently chosen to re-finance $500 million of its outstanding Restricted Tier 1 ("RT1") notes callable in early 2025 through a tender exercise, and successfully issued $500 million of new RT1 notes at a $ coupon of 8.5%.

The Group has therefore reduced its outstanding debt by £250 million, with its annual debt interest costs broadly unchanged after this redemption and refinancing exercise. As a result, the Group maintains its strong cash interest cover of c.6 times.


Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs and Investor Relations, Phoenix Group

+44 (0)20 4559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 4559 3145

Media:

Douglas Campbell, Teneo

+44 (0)7753 136 628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 4559 3031


Legal Disclaimers

This announcement in relation to Phoenix Group Holdings plc and its subsidiaries (the 'Group') contains, and the Group may make other statements (verbal or otherwise) containing, forward-looking statements and other financial and/or statistical data about the Group's current plans, goals, ambitions, outlook, guidance and expectations relating to future financial condition, performance, results, strategy and/or objectives.

Statements containing the words: 'believes', 'intends', 'will', 'may', 'should', 'expects', 'plans', 'aims', 'seeks', 'targets', 'continues' and 'anticipates' or other words of similar meaning are forward looking. Such forward-looking statements and other financial and/or statistical data involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. For example, certain insurance risk disclosures are dependent on the Group's choices about assumptions and models, which by their nature are estimates. As such, actual future gains and losses could differ materially from those that the Group has estimated.

Other factors which could cause actual results to differ materially from those estimated by forward-looking statements include, but are not limited to: domestic and global economic, political, social, environmental and business conditions; asset prices; market related risks such as fluctuations in investment yields, interest rates and exchange rates, the potential for a sustained low-interest rate or high-interest rate, environment, and the performance of financial or credit markets generally; the policies and actions of governmental and/or regulatory authorities, including, for example, initiatives related to the financial crisis, the COVID-19 pandemic, climate change and the effect of the UK's version of the "Solvency II" regulations on the Group's capital maintenance requirements; the impact of changing inflation rates (including high inflation) and/or deflation; the medium and long-term political, legal, social and economic effects of the COVID-19 pandemic and the UK's exit from the European Union; the direct and indirect consequences of the European and global macroeconomic conditions of the Russia-Ukraine War and related or other geopolitical conflicts; information technology or data security breaches (including the Group being subject to cyberattacks); the development of standards and interpretations including evolving practices in ESG and climate reporting with regard to the interpretation and application of accounting; the limitation of climate scenario analysis and the models that analyse them; lack of transparency and comparability of climate-related forward-looking methodologies; climate change and a transition to a low-carbon economy (including the risk that the Group may not achieve its targets); market competition; changes in assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, gender pricing and lapse rates); the timing, impact and other uncertainties of proposed or future acquisitions, disposals or combinations within relevant industries; risks associated with arrangements with third parties; inability of reinsurers to meet obligations or unavailability of reinsurance coverage; the impact of changes in capital, and implementing changes in IFRS 17 or any other regulatory solvency and/or accounting standards, and tax and other legislation and regulations in the jurisdictions in which members of the Group operate.

As a result, the Group's actual future financial condition, performance and results may differ materially from the plans, goals, ambitions, outlook, guidance and expectations set out in the forward-looking statements and other financial and/or statistical data within this announcement. The Group undertakes no obligation to update any of the forward-looking statements or data contained within this announcement or any other forward-looking statements or data it may make or publish. Nothing in this announcement constitutes, nor should it be construed as, a profit forecast or estimate.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction. The securities referred to above have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any relevant securities laws of any state of the United States and may not be offered or sold to U.S. persons or to persons within the United States, except pursuant to an exemption from the Securities Act.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXKNFEFLEFA
Date   Source Headline
17th Apr 202012:00 pmRNS2020 AGM - Revised Arrangements
14th Apr 20205:15 pmRNSHolding(s) in Company
9th Apr 20204:15 pmRNSHolding(s) in Company
9th Apr 202011:00 amRNSDirector/PDMR Shareholding
31st Mar 20202:00 pmRNSTotal Voting Rights
27th Mar 20209:00 amRNSDirector/PDMR Shareholding
27th Mar 20209:00 amRNSDirector/PDMR Shareholding
23rd Mar 20204:25 pmRNSNotice of AGM
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
17th Mar 20203:00 pmRNSDirector/PDMR Shareholding
16th Mar 20205:15 pmRNSDirector/PDMR Shareholding
16th Mar 20203:30 pmRNSDirector/PDMR Shareholding
16th Mar 20203:30 pmRNSDirector/PDMR Shareholding
12th Mar 20203:45 pmRNSDirector/PDMR Shareholding
12th Mar 20203:45 pmRNSDirector/PDMR Shareholding
11th Mar 202010:30 amRNSDirector/PDMR Shareholding
10th Mar 20204:45 pmRNSHolding(s) in Company
10th Mar 20203:15 pmRNSPublication of Suppl.Prospcts
9th Mar 202012:45 pmRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirectorate Change
9th Mar 20207:00 amRNS2019 Annual Financial Results
3rd Mar 20205:30 pmRNSHolding(s) in Company
28th Feb 20202:30 pmRNSTotal Voting Rights
13th Feb 202010:55 amRNSResults of General Meeting
11th Feb 20207:00 amRNSBoard Changes
10th Feb 202011:00 amRNSDirector/PDMR Shareholding
31st Jan 20202:00 pmRNSTotal Voting Rights
27th Jan 20203:45 pmRNSPublication of Offering Memorandum
27th Jan 202010:00 amRNSHolding(s) in Company
24th Jan 20204:00 pmRNSHolding(s) in Company
17th Jan 20204:00 pmRNSPublication of Suppl.Prospcts
17th Jan 20203:30 pmRNSPublication of a Prospectus
8th Jan 20202:30 pmRNSDirector/PDMR Shareholding
31st Dec 20199:00 amRNSTotal Voting Rights
19th Dec 20192:00 pmRNSBlock listing Return
9th Dec 20194:00 pmRNSDirector/PDMR Shareholding
6th Dec 20197:00 amRNSProposed acquisition of ReAssure Group plc
29th Nov 20192:00 pmRNSTotal Voting Rights
28th Nov 20197:00 amRNSPhoenix Group Holdings plc - Trading Update
8th Nov 20197:00 amRNSPhoenix Group Holdings plc - Board Changes
6th Nov 20193:00 pmRNSDirector/PDMR Shareholding
31st Oct 201910:15 amRNSTotal Voting Rights
9th Oct 201912:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20192:45 pmRNSDirector/PDMR Shareholding
30th Sep 201912:15 pmRNSTotal Voting Rights
9th Sep 20194:15 pmRNSDirector/PDMR Shareholding
30th Aug 20191:15 pmRNSTotal Voting Rights
27th Aug 201911:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.